Cell line name |
DS179 |
Synonyms |
DS 179 |
Accession |
CVCL_W747 |
Resource Identification Initiative |
To cite this cell line use: DS179 (RRID:CVCL_W747) |
Sequence variations |
- Mutation; HGNC; 11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (PubMed=8344493).
|
Disease |
B-cell non-Hodgkin lymphoma (NCIt: C3457) B-cell non-Hodgkin lymphoma (ORDO: Orphanet_171915) |
Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
Category |
Cancer cell line |
Publications | PubMed=6286763; DOI=10.4049/jimmunol.129.3.1336 Benjamin D., Magrath I.T., Maguire R.T., Janus C., Todd H.D., Parsons R.G. Immunoglobulin secretion by cell lines derived from African and American undifferentiated lymphomas of Burkitt's and non-Burkitt's type. J. Immunol. 129:1336-1342(1982) PubMed=1325212; DOI=10.1182/blood.V80.5.1289.1289 Benjamin D., Knobloch T.J., Dayton M.A. Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood 80:1289-1298(1992) PubMed=8220424; DOI=10.1038/ng0993-56 Bhatia K.G., Huppi K., Spangler G., Siwarski D., Iyer R., Magrath I.T. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nat. Genet. 5:56-61(1993) PubMed=8344493; DOI=10.1096/fasebj.7.10.8344493 Bhatia K.G., Goldschmidts W., Gutierrez M.I., Gaidano G., Dalla-Favera R., Magrath I.T. Hemi- or homozygosity: a requirement for some but not other p53 mutant proteins to accumulate and exert a pathogenetic effect. FASEB J. 7:951-956(1993) |
Cross-references |
Cell line databases/resources |
cancercelllines; CVCL_W747
|
Encyclopedic resources |
Wikidata; Q54831439
|
Polymorphism and mutation databases |
Cosmic; 2808225
|
Entry history |
Entry creation | 17-Jul-2014 |
Last entry update | 05-Oct-2023 |
Version number | 14 |
---|